Publications by authors named "Mark Groves"

Claim this Profile
T
The highly anxious individual presenting for Huntington disease-predictive genetic testing: the psychiatrist's role in assessment and counseling.
Mark Groves

Handb Clin Neurol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychiatric and Cognitive Effects of Deep Brain Stimulation for Parkinson's Disease.
Adam Nassery, Christina A Palmese, Harini Sarva, Mark Groves, Joan Miravite

Curr Neurol Neurosci Rep· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clozapine Treatment for Impulse Control Disorders in Parkinson's Disease Patients: A Case Series.
John Liang, Mark Groves, Vicki L Shanker

Mov Disord Clin Pract· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study.
John W Liang, Vicki L Shanker, Mark Groves

Neurology· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations.
Roy N Alcalay, Anat Mirelman, Rachel Saunders-Pullman, Ming-X Tang, Helen Mejia Santana, Mark Groves

Mov Disord· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study.
Eric A Epping, James A Mills, Leigh J Beglinger, Jess G Fiedorowicz, David Craufurd, Mark Groves

J Psychiatr Res· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An International Survey-based Algorithm for the Pharmacologic Treatment of Obsessive-Compulsive Behaviors in Huntington's Disease.
Karen Anderson, David Craufurd, Mary C Edmondson, Nathan Goodman, Mark Groves

PLoS Curr· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mood and cognition in leucine-rich repeat kinase 2 G2019S Parkinson's disease.
Vicki Shanker, Mark Groves, Gary Heiman, Christina Palmese, Rachel Saunders-Pullman

Mov Disord· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An International Survey-based Algorithm for the Pharmacologic Treatment of Irritability in Huntington's Disease.
Mark Groves, Erik van Duijn, Karen Anderson, David Craufurd, Mary C Edmondson

PLoS Curr· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing behavioural manifestations prior to clinical diagnosis of huntington disease: "anger and irritability" and "obsessions and compulsions".
Anthony L Vaccarino, Anonymous, Karen E Anderson, Beth Borowsky, Emil Coccaro, Mark Groves

PLoS Curr· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of depression, anxiety and apathy in prodromal and early huntington disease.
Anthony L Vaccarino, Terrence Sills, Karen E Anderson, Anne-Catherine Bachoud-Lévi, Beth Borowsky, Mark Groves

PLoS Curr· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parkinson's disease as a model for psychosocial issues in chronic neurodegenerative disease.
Mark S Groves, David V Forrest

Adv Neurol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis